Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Alginor, Ibscim
Synonyms :
cimetropium ion, cimetropium bromide
Class :
Neuropsychiatric agent, Muscarinic cholinergic receptor antagonist
Brand Name :
Alginor, Ibscim
Synonyms :
cimetropium ion, cimetropium bromide
Class :
Neuropsychiatric agent, Muscarinic cholinergic receptor antagonist
Dosage forms& StrengthsÂ
TabletÂ
50 mgÂ
Irritable Bowel Syndrome (IBS)Â
It is indicated in the treatment of IBS
The recommended usual dose via oral administration is 50 mg three times per day
Dose Adjustments
Limited data is available
Safety and efficacy studies are not seen in pediatricsÂ
Refer to the adult dosingÂ
cimetropium: they may increase the CNS depressant effect of CNS Depressants
cimetropium: they may increase the CNS depressant effect of CNS Depressants
cimetropium: they may increase the CNS depressant effect of CNS Depressants
cimetropium: they may increase the CNS depressant effect of CNS Depressants
cimetropium: they may increase the CNS depressant effect of CNS Depressants
cimetropium: they may increase the bradycardic effect of Bradycardia-Causing Agents
cimetropium: they may increase the bradycardic effect of Bradycardia-Causing Agents
cimetropium: they may increase the bradycardic effect of Bradycardia-Causing Agents
cimetropium: they may increase the bradycardic effect of Bradycardia-Causing Agents
cimetropium: they may increase the bradycardic effect of Bradycardia-Causing Agents
cimetropium: they may enhance the serum concentration of CYP3A4 Inhibitors
cimetropium: they may enhance the serum concentration of CYP3A4 Inhibitors
cimetropium: they may enhance the serum concentration of CYP3A4 Inhibitors
cimetropium: they may enhance the serum concentration of CYP3A4 Inhibitors
cimetropium: they may enhance the serum concentration of CYP3A4 Inhibitors
acrivastine and pseudoephedrineÂ
may increase the anticholinergic effect of anticholinergic agents
may have an increased anticholinergic effect when combined with cimetropium
may have an increased anticholinergic effect when combined with cimetropium
may have an increased anticholinergic effect when combined with cimetropium
may have an increased anticholinergic effect when combined with cimetropium
may have an increased anticholinergic effect when combined with cimetropium
anticholinergic agents increase the efficacy of cimetropium
anticholinergic agents increase the efficacy of cimetropium
anticholinergic agents increase the efficacy of cimetropium
anticholinergic agents increase the efficacy of cimetropium
anticholinergic agents increase the efficacy of cimetropium
anticholinergic agents increase the effect of cimetropium
anticholinergic agents increase the effect of cimetropium
anticholinergic agents increase the effect of cimetropium
anticholinergic agents increase the effect of cimetropium
anticholinergic agents increase the effect of cimetropium
cimetropium: they may increase the CNS depressant effect of CNS Depressants
cimetropium: they may increase the CNS depressant effect of CNS Depressants
cimetropium: they may increase the CNS depressant effect of CNS Depressants
cimetropium: they may enhance the serum concentration of CYP2D6 Inhibitors
cimetropium: they may enhance the serum concentration of CYP2D6 Inhibitors
cimetropium: they may enhance the serum concentration of CYP2D6 Inhibitors
cimetropium: they may enhance the serum concentration of CYP2D6 Inhibitors
cimetropium: they may enhance the serum concentration of CYP2D6 Inhibitors
may increase the anticholinergic effect of anticholinergic agents
may increase the anticholinergic of anticholinergic agents
may increase the anticholinergic effect of anticholinergic agents
may increase the anticholinergic effect of anticholinergic agents
may increase the anticholinergic effect of Anticholinergic Agents
promethazine/dextromethorphanÂ
may increase the anticholinergic effect of Anticholinergic Agents
may increase the anticholinergic effect of Anticholinergic Agents
cimetropium: they may increase the hypertensive effect of sympathomimetics
cimetropium: they may increase the hypertensive effect of sympathomimetics
cimetropium: they may increase the hypertensive effect of sympathomimetics
cimetropium: they may increase the hypertensive effect of sympathomimetics
cimetropium: they may increase the hypertensive effect of sympathomimetics
the anticholinergic activities of cimetropium may be reduced by acetylcholine
when combined with cimetropium, there is an increased chances of adverse effects with aclidinium
the anticholinergic activities of cimetropium may be reduced by bethanechol
may decrease the anticholinergic effect of cholinergic agonists
the adverse effects of amitriptyline may be increased when combined with cimetropium
when amoxapine is combined with cimetropium, the chances of adverse effects may be increased
when combined with cimetropium, there is an increased risk or severity of adverse effects with aripiprazole
the adverse effects of benzatropine may be increased when combined with cimetropium
Actions and spectrum:Â
Cimetropium bromide is a medicine that helps in easing stomach discomfort by stopping and calming the intestines from shrinking because it’s in the group of anti-spasmodic as well as anti-cholinergic drugs.Â
Adverse reactionsÂ
TachycardiaÂ
Dry skinÂ
FlushingÂ
BradycardiaÂ
Dry mouthÂ
Difficulty urinatingÂ
PalpitationsÂ
Reduced bronchial secretionsÂ
ArryhtmiasÂ
Reduced GI toneÂ
Pupil dilationÂ
NauseaÂ
VomitingÂ
FeverÂ
SleeplessnessÂ
CoughÂ
Skin rashÂ
HeadacheÂ
DizzinessÂ
ItchingÂ
Loss of accommodationÂ
Black box warningÂ
This medication is not recommended for use in individuals with certain medical conditions, including glaucoma, intestinal obstruction, prostatic hyperplasia, cardiac arrhythmias, urinary retention, chronic airway obstruction, reflux esophagitis, and congestive heart failure.Â
Contraindications/CautionÂ
ContraindicationsÂ
HypersensitivityÂ
Prostatic enlargementÂ
Pyrolic stenosisÂ
Paralytic ileusÂ
CautionsÂ
Renal impairmentÂ
DiarrheaÂ
ThyrotoxicosisÂ
FeverÂ
Hepatic impairmentÂ
Cardiac surgery or heart failureÂ
Drug interactionsÂ
Pregnancy Â
BreastfeedingÂ
Pregnancy & breastfeeding:Â
Pregnancy consideration:Â
Data about the safety and efficacy studies in pregnancy is not availableÂ
Breastfeeding warnings:Â
Data regarding the secretion of drug into human milk is not availableÂ
Pregnancy category:Â
Pharmacology:Â
Cimetropium, a semi-synthetic alkaloid obtained from belladonna derived from scopolamine. It is an antispasmodic and antimuscarinic agent.Â
Pharmacodynamics:Â
Cimetropium bromide is an anticholinergic agent that works by preventing muscarinic cholinergic receptors from functioning, without regard to their specific type. As a result of this blockage, the production of cyclic guanosine monophosphate (cGMP) is decreased leading to reduced smooth muscle contractility which may be due predominantly via decreased intracellular calcium action mediated by cGMP.Â
Pharmacokinetics:Â
Limited data availableÂ
Administration:Â
This tablet should be taken orally, with or without food. It would be better to administer this tablet on the same time every day.Â
Patient information leafletÂ
Generic Name: cimetropiumÂ
Why do we use cimetropium?Â
This is an antispasmodic and antimuscarinic agent indicated in treating irritable bowel syndrome. It works by causing relaxation of the intestinal muscles.Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
